Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Clinical trials ran for 68 weeks (approximately 16 months), with participants losing an average of 14.9% of total body weight
Other GLP-1 injections available through the Hers platform include: Wegovy
healthy postmenopausal females only) and a multiple dose part (part II
Topical and Nasal AOD-9604 Topical and nasal forms appear in marketing, but the FDA review found no published human exposure data for transdermal or intranasal AOD-9604
We continue to stay abreast of ongoing research to ensure our patients benefit from the latest insights into the comparative benefits and risks of these two GLP-1 receptor agonists in the management of type 2 diabetes
US$ 22.77
US$ 27.91
US$ 25.19
